Smith & Nephew Plc
22 September 2003
SMITH & NEPHEW APPOINTS ENDOSCOPY PRESIDENT
22 September 2003
Smith & Nephew plc today announces the appointment of Jim Taylor as President of
its Endoscopy business.
Mr Taylor, 47, joined Smith & Nephew in 2000 as a Group Director responsible for
25 country markets for the Orthopaedics, Endoscopy and Wound Management
businesses. He is a current member of the Smith & Nephew Group Executive
Committee.
Mr Taylor, who will be based at Endoscopy Division headquarters in Andover,
Massachusetts, has wide executive experience in the medical devices arena and a
strong background in global business operations. His experience encompasses
several roles at DePuy, including President of DePuy International, as well as
positions in the automotive industry.
He replaces former divisional president Ron Sparks, who left the company earlier
this month to take over as Chief Executive Officer of UTI Corporation in
Philadelphia.
Smith & Nephew Chief Executive Chris O'Donnell said 'Jim Taylor has
consistently shown leadership and strong results in building Smith & Nephew's
international business. He understands the Endoscopy sector well and I have
every confidence that he will be a strong leader for this business.'
Enquiries:
Smith & Nephew
Angie Craig Tel: +44 (0)20 7401 7646
Corporate Affairs Director
Financial Dynamics
David Yates Tel: +44 (0)20 7831 3113
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.